Targeted Partnerships Pharmacogenomics focus positions RxGenomix as a strategic partner for hospitals, clinics, and health systems seeking personalized medicine programs; explore collaborations with medical groups and IT vendors to integrate PGx decision support into workflows.

Clinical Value Highlight potential for reduced adverse drug events and optimized dosing to drive cost savings and improved outcomes, creating a compelling ROI case for payer discussions, risk management teams, and value-based care initiatives.

Expansion Readiness With a small team and growth-stage profile, target mid-sized health networks and specialty clinics likely to outsource pharmacogenomics services, offering managed implementation, training, and ongoing clinical support.

Operational Levers Leverage existing partnerships and training programs (CLS, Translational Software, CHC Health) to upsell broad PGx implementation, training scalability, and data analytics capabilities to enterprise clients.

Technology Enablement Position as a turnkey PGx-enabled platform compatible with common healthcare IT stacks (cloud services, analytics tools, and patient care workflows) to attract procurement from health systems seeking interoperability and rapid deployment.